Recent News


Important Information

from the State Medical Board of Ohio

Proposed Creation of Confidential Monitoring Program Bookmark

The State Medical Board of Ohio (“Medical Board”) invites interested parties to comment on proposed rules that will create a non-disciplinary, confidential monitoring program that allows licensees with mental or physical illnesses, other than substance use disorders, to be monitored by the Medical Board without being subjected to formal public disciplinary action. The program will be entirely within the Medical Board’s investigative process and overseen by the Secretary and Supervising Member of the Medical Board.

If the proposed confidential monitoring program is created, there will be three possible results should the Medical Board receive a complaint alleging that an applicant or licensee is unable to safely practice due to mental or physical illness, excluding substance use disorders. The three possibilities are: (1) the complaint is closed after review, with no public disclosure; (2) the individual is entered into the confidential monitoring program, with no public disclosure; or (3) formal disciplinary action against the individual is proposed, with the action being publicly disclosed. The proposed rules are as follows:

4731-28-02 Eligibility for confidential monitoring program

4731-28-03 Participation in the confidential monitoring program

4731-28-04 Disqualification from continued participation in the confidential monitoring program

4731-28-05 Termination of the participation agreement for the confidential monitoring program


Send comments to by Monday, May 1, 2017. 

Board Seeks Comments Regarding Proposed Acute Pain Rules Bookmark

The Medical Board is accepting comments on proposed amendments to two existing rules and a proposed new rule that will limit initial opioid analgesic prescriptions for acute pain to 5 days for minors and 7 days for adults. The rules also include a 30MED average daily dose limit. 

(1) Rule 4731-11-01 Definitions Amended by adding definitions for acute pain, morphine equivalent dose, minor, extended-release or long-acting opioid analgesic, opioid analgesic, palliative care and terminal condition.

(2) Rule 4731-11-02 General Provisions Amended by adding a requirement that physicians and physician assistants must follow Rules 4729-5-30 and 4729-5-13, Ohio Administrative Code. This will include the requirement that prescriptions for controlled substances will need to include the diagnosis.

(3) New Rule 4731-11-13 Prescribing of opioid analgesics for acute pain

  • Limits prescriptions for opioid analgesics to treat acute pain to no more than a seven-day supply for adults and a five-day supply for minors. If the physician determines that the pain is expected to persist for longer than seven days, the physician may prescribe for a longer period, but the reason for exceeding the limits and for prescribing an opioid analgesic must be documented in the patient’s medical record.

  • Requires that the patient and the parent or guardian of a minor patient is advised of the benefits and risks of the opioid analgesic, including the potential for addiction.

  • Clarifies that the rule does not apply to the treatment of patients receiving hospice or palliative care, cancer and terminal illness, or medication assisted treatment for addiction.

​*These proposed rules do not apply to your chronic (long-term) pain patients.


Send comments to by Friday, April 28, 2017.

Renewal System Downtime Bookmark

IMPORTANT – License Renewal Information

The State Medical Board of Ohio will be changing online licensure websites in June 2017. All systems are anticipated to be unavailable from June 2 – June 19. You will not be able to renew your license during the outage.

  • Physicians and Training Certificate holders with an approaching renewal deadline: You are strongly encouraged to renew your license BEFORE June 2. Log on to to get started. Chrome will not work properly with the physician online renewal website. Use a compatible browser such as Internet Explorer or Safari.

  • All other license holders with a July 1, 2017 renewal deadline: Consider renewing before June 2 to avoid system outages. Click here to renew: Chrome is the preferred browser for the elicense system.

Renewing early does not change future license expiration dates. Paper licensure applications for MD, DO, DPM and training certificates will not be accepted after June 19.

OARRS Site Downtime Bookmark

Important Information Regarding Your OARRS Account

The Ohio Automated Rx Reporting System (OARRS) is upgrading to the PMP AWARxE software platform on Tuesday, April 25, 2017.

On April 20, 2017, The OARRS registration function will be disabled to allow for the upgrade to the new system. Anyone wishing to register for an OARRS account should register prior to April 20, 2017. 

For additional information about the upcoming transition, including information regarding the transfer of your OARRS account, please visit:

CT Exam Date Set for July 7 Bookmark

The date of the next Cosmetic Therapy exam will be Friday, July 7, 2017. The application must be submitted before 5pm Monday, June 26, 2017. Click here to submit an application.

Website Downtime Bookmark

Part of the State Medical Board of Ohio’s online system will be down for maintenance on Thursday, April 6th. From 6-9p.m. users will not be able to access any information on the following licenses during that time:

Cosmetic therapist, massage therapists, physician assistants, acupuncturist, oriental medicine, anesthesiologist assistants, radiologist assistants, genetic counselor, limited branch schools.

Acute Prescribing Rules Proposed Bookmark

Board President, Dr. Amol Soin, joined Governor John R. Kasich and other leadership to announce new limits on prescription opiates on Thursday, March 30. The state began creating its voluntary guidelines in 2012. After close analysis of the state’s electronic prescribing data in OARRS, Ohio will now take the next step to update its policies to place commonsense limits on opiate prescribing for acute pain. The changes can lead to an estimated reduction of opiate doses in Ohio by 109 million per year while preserving the ability of clinicians to address pain in a competent and compassionate way. These proposed rules will be discussed by the Medical Board during the April 12 policy committee meeting and then proceed into Ohio’s standard rule review and adoption process. Further information and specific prescribing information will be provided by the State Medical Board of Ohio once the rules are finalized, but before they become effective.


Acute Prescribing Rules FAQs

For more information on the proposed rules, click here.

The State Medical Board of Ohio recognizes and celebrates physicians on National Doctors' Day 2017. Bookmark

The State Medical Board of Ohio recognizes and celebrates physicians on National Doctors' Day 2017.

In 1990, legislation was introduced in the House and Senate to establish a national Doctors' Day. Following overwhelming approval by the United States Senate and the House of Representatives, on October 30, 1990, President George H. W. Bush designated March 30th as "National Doctors' Day.

March 30th was selected because it is the anniversary of the first use of general anesthesia in surgery.

Update for Prescribers Bookmark

The Ohio Board of Pharmacy has recently published a number of guidance documents regarding recent law and rule changes that may impact your prescribing practices.

  • TDDD Requirements for Controlled Substances: All locations that possess controlled substances are required to obtain licensure as a category III terminal distributor of dangerous drugs. Please be advised that this requirement takes effect on April 6, 2017. More information on this provision can be found by visiting:

  • Office-Based Opioid Treatment: Effective August 4, 2017, all locations that treat more than 30 individuals for opioid dependence or addiction using a controlled substance are required to obtain a license as a terminal distributor of dangerous drugs with an office-based opioid treatment classification. Please be advised that there are some exemptions to this requirement. More information on this provision can be found by visiting:

  • Effective April 1, 2017, all prescribers that possess compounded drugs or engage in the compounding of dangerous drugs (i.e. prescription drugs) must obtain a license as a terminal distributor of dangerous drugs (ORC 4729.541). More information on this provision can be found at: